In this study, the elevated expression of BTNL9 blocked breast cancer cells in G2/M via P53/CDC25C and P53/GADD45 pathways [41], suggesting that BTNL9 could be a promising biomarker for the early detection of breast cancer, thereby enabling timely and effective treatment. Here, TP53 is linked to breast carcinoma.